Figure (352882b7 80a3 4940 Bf4b F3ba3195d2d1 00)
Zyclara Cream
Product Images NDC 99207-271
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zyclara (NDC 99207-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 01
Image 02
Image 03
ZycClara cream is a medication containing Imiquimod 3.75%, used to treat certain skin conditions by stimulating the immune system. It is important to read the accompanying insert for dosage recommendations, directions for use, and other information. The cream must be stored at a controlled room temperature not exceeding 30°C and kept out of reach of children. Each gram of the cream contains 37.5 mg of Imiquimod in a cream base made of various ingredients. ZycClara is a trademark of Bausch Health Companies Inc. and its affiliates. The product is distributed by Bausch Health US LLC and manufactured by Bausch Health Companies Inc. Product of Canada. This is a prescription-only medication, and one pack delivers no fewer than 28 full actuations.*
Image 04
Zyclara (imiquimod) Cream 375% is a topical medication that comes in a box containing 28 single-use packets, with a net weight of 0.25 g per packet and 7 g per box. It is not meant for use in the eyes, mouth, or vagina. The other text appears to be random letters and numbers and does not provide any further useful information.*
Chemical Structure (Zyclara 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
